World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
79
Citations
22405
World Ranking
4317
National Ranking
2102

Medicine

D-Index
80
Citations
22642
World Ranking
17147
National Ranking
8592

Pedro R. Lowenstein publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Pedro R. Lowenstein sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 528 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Pedro R. Lowenstein D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Pedro R. Lowenstein sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 79 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2018 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Pedro R. Lowenstein is affiliated with the University of Michigan-Ann Arbor in the United States. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology, with specific contributions in the subfields of genetics, molecular biology, immunology, oncology, and cancer research.

The scientist has been involved extensively in topics including glioma diagnosis and treatment, virus-based gene therapy research, immune cells in cancer, immunotherapy and immune responses, epigenetics and DNA methylation, CAR-T cell therapy research, and cell image analysis techniques.

Frequently published venues for their research include Neuro-Oncology, bioRxiv (Cold Spring Harbor Laboratory), Cancer Research, Nature Communications, and Frontiers in Oncology.

Some of their recent papers are:

  • Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy, 2020, Nature Communications
  • Purine metabolism regulates DNA repair and therapy resistance in glioblastoma, 2020, Nature Communications
  • Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging, 2023, Nature Medicine
  • Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice, 2020, Journal of Clinical Investigation
  • Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy, 2022, ACS Nano

Collaborators who have frequently co-authored works with this scientist include María G. Castro, Syed Mohd Faisal, Andrea Comba, María L. Varela, and Padma Kadiyala.

Pedro R. Lowenstein's career achievements include recognition as a Fellow of the American Association for the Advancement of Science (AAAS) awarded in 2018 and membership in the Association of American Physicians.

Best Publications

  • The Collaborative Cross, a community resource for the genetic analysis of complex traits

    Gary A. Churchill;David C. Airey;Hooman Allayee;Joe M. Angel

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

  • Nicotinic acetylcholine binding sites in Alzheimer's disease.

    Peter J. Whitehouse;Andrea M. Martino;Piero G. Antuono;Pedro R. Lowenstein

  • Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials.

    R. A. Dewey;G. Morrissey;C. M. Cowsill;D. Stone

  • Platelets Mediate Cytotoxic T Lymphocyte-Induced Liver Damage.

    Matteo Iannacone;Giovanni Sitia;Masanori Isogawa;Patrizia Marchese

  • Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression

    Marianela Candolfi;Marianela Candolfi;James F. Curtin;James F. Curtin;W. Stephen Nichols;A. K.M.G. Muhammad

  • HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression

    James F Curtin;James F Curtin;Naiyou Liu;Naiyou Liu;Marianela Candolfi;Marianela Candolfi;Weidong Xiong;Weidong Xiong

  • Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: toward realistic long-term neurological gene therapy for chronic diseases.

    Clare E. Thomas;Gudrun Schiedner;Stefan Kochanek;Maria G. Castro

  • Regulatable Gene Expression Systems for Gene Therapy Applications: Progress and Future Challenges

    Shyam Goverdhana;Mariana Puntel;Weidong Xiong;Jeffrey M Zirger

  • Response of Foot-and-Mouth Disease Virus to Increased Mutagenesis: Influence of Viral Load and Fitness in Loss of Infectivity

    Saleta Sierra;Mercedes Dávila;Pedro R. Lowenstein;Esteban Domingo

  • Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy

    Jason V. Gregory;Padma Kadiyala;Robert Doherty;Melissa Cadena

  • Progress in gene therapy for neurological disorders

    Michele Simonato;Jean Bennett;Nicholas M. Boulis;Maria G. Castro

  • Current and future strategies for the treatment of malignant brain tumors

    M.G Castro;R Cowen;I.K Williamson;I.K Williamson;A David

  • ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma

    Carl Koschmann;Anda-Alexandra Calinescu;Felipe J. Nunez;Alan Mackay

  • Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity.

    Adrian E. Morelli;Adriana T. Larregina;Joseph Smith-Arica;Ricardo A. Dewey

  • Immune Responses to Adenovirus and Adeno-Associated Vectors Used for Gene Therapy of Brain Diseases: The Role of Immunological Synapses in Understanding the Cell Biology of Neuroimmune Interactions

    Pedro R. Lowenstein;Ronald J. Mandel;Wei Dong Xiong;Kurt Kroeger

  • Suppression of viral infectivity through lethal defection

    Ana Grande-Pérez;Ester Lázaro;Pedro Lowenstein;Esteban Domingo

  • IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.

    Felipe J. Núñez;Flor M. Mendez;Padma Kadiyala;Mahmoud S. Alghamri

  • Efficient Virus Extinction by Combinations of a Mutagen and Antiviral Inhibitors

    Nonia Pariente;Saleta Sierra;Pedro R. Lowenstein;Esteban Domingo

  • Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain.

    Clare E. Thomas;Darren Birkett;Ijeoma Anozie;Maria G. Castro

Frequent Co-Authors

Maria G. Castro
Maria G. Castro University of Michigan–Ann Arbor
David Altshuler
David Altshuler Harvard University
David Klatzmann
David Klatzmann Sorbonne University
Chris M. Preston
Chris M. Preston University of Glasgow
Alan K. Meeker
Alan K. Meeker Johns Hopkins University School of Medicine
Daniel P. Cardinali
Daniel P. Cardinali Pontifical Catholic University of Argentina
Costas A. Lyssiotis
Costas A. Lyssiotis University of Michigan–Ann Arbor
James J. Moon
James J. Moon University of Michigan–Ann Arbor
Joseph T. Coyle
Joseph T. Coyle Harvard University
Henry D. Appelman
Henry D. Appelman University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Pedro R. Lowenstein

Trending Scientists